Literature DB >> 19020980

STROBE and STREGA: instruments for improving transparency and quality of reporting scientific results.

Dag Steinar Thelle1.   

Abstract

Mesh：

Year:  2008        PMID： 19020980     DOI： 10.1007/s10654-008-9303-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  6 in total

1.  Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Authors:  M J Stampfer; G A Colditz
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

Review 2.  Hormone replacement therapy and coronary heart disease in women: a review of the evidence.

Authors:  Annette K Low; Lori D Russell; Honey E Holman; Jinna M Shepherd; G Swink Hicks; C Andrew Brown
Journal:  Am J Med Sci       Date:  2002-10       Impact factor: 2.378

3.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

Review 4.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  G Bjelakovic; D Nikolova; L L Gluud; R G Simonetti; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

5.  Comparing methods for handling missing values in food-frequency questionnaires and proposing k nearest neighbours imputation: effects on dietary intake in the Norwegian Women and Cancer study (NOWAC).

Authors:  Christine L Parr; Anette Hjartåker; Ida Scheel; Eiliv Lund; Petter Laake; Marit B Veierød
Journal:  Public Health Nutr       Date:  2007-07-02       Impact factor: 4.022

Review 6.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069
  6 in total
  7 in total

1.  Genetic variations in KIFC1 and the risk of aspirin exacerbated respiratory disease in a Korean population: an association analysis.

Authors:  Charisse Flerida A Pasaje; Joon Seol Bae; Byung-Lae Park; Jeong-Hyun Kim; Hyun Sub Cheong; Soo-Taek Uh; Choon-Sik Park; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2011-12-27       Impact factor: 2.316

2.  Towards a more functional concept of causality in cancer research.

Authors:  Eiliv Lund; Vanessa Dumeaux
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-15

3.  New studies, technology, and the progress of epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-12       Impact factor: 8.082

4.  Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.

Authors:  José Luis Izquierdo; Arturo Martínez; Elizabet Guzmán; Pilar de Lucas; José Miguel Rodríguez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-11-08

5.  The Generation R Study: design and cohort update 2010.

Authors:  Vincent W V Jaddoe; Cock M van Duijn; Albert J van der Heijden; Johan P Mackenbach; Henriëtte A Moll; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-10-22       Impact factor: 8.082

Review 6.  Cardiovascular and metabolic influences of fetal smoke exposure.

Authors:  Hanneke Bakker; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2011-10-13       Impact factor: 8.082

Review 7.  Genetic polymorphisms in homocysteine metabolism and response to folate intake: a comprehensive strategy to elucidate useful genetic information.

Authors:  Koichi Miyaki
Journal:  J Epidemiol       Date:  2010-06-19       Impact factor: 3.211
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.